You can’t do the research on mosunetuzumab, Fecal microbiota, live - jslm, and teclistamab, which are the new drugs are important targets for the observational research.
I understand that postprocessing instead of logic of incorporated into staging process has some risk of errors. But what errors will you get? errors with these reused concepts. Now they don’t work at all. So you can’t do it worse:)
Anyway, let’s discuss offline how I can help.
True, it’s hard to implement the full solution. Even because of everyone has to change their vocabulary upload scripts.
Here’s the simpler solution:
let’s keep the latest meaning of HCPCS code in the OHDSI vocabulary.
it’s better because
it’s consistent
NDC is already done this way,
there 3 HCPCS codes already have new meaning
concept_code
concept_name
Q2040
Tisagenlecleucel, up to 250 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per infusion (Deprecated)
Q2041
Axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Q2042
Tisagenlecleucel, up to 600 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
New meanings are more likely to be researched since they represent the new drugs or procedures